Systematic enquiries are now made about every case of CO poisoning in the Midi-Pyrénées. The present study aims to amass more cases and to start more technical enquiries. Eventually it is hoped to develop a regional hospital surveillance system in co-operation with the hyperbaric oxygen centre. Over the 2 years from September 1993 to September 1995 there were 283 cases of CO poisoning in the Midi-Pyrénées region which resulted in 222 hospitalisations. Analysis of the cases showed that poisoning by CO was most often acute, accidental, involved a group of people and generally occurred by pollution of the domestic environment. The most frequent reason was lack of ventilation which was found in 33.3% of cases. Water heaters and boilers were responsible in 46.6% of cases and water heaters alone were responsible for 22% of cases. Poisonings most often occurred in the winter period when there was greater use of heating. An awareness of the importance of safety and the necessity to take preventive action to avoid such poisoning has led to the creation of ’Qualigaz’ in 1992. This organisation can carry out ‘safety checks’ on new installations and diagnostic work on the safety of existing installations.

Keywords:
CO poisoning, Incidence, Severity, Causes
This content is only available via PDF.
© 1999 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.